Middle East Pharmaceutical Company Ltd. (4016)
Market Closed
10 Aug, 12:00
XSAU 
JPX Primary XSAU ﷼
61. 75
+0.45
+0.7341%
﷼
- Market Cap
- P/E Ratio
120% Div Yield
88,254 Volume
- Eps
﷼ 61.3
Previous Close Want to track 4016 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Middle East Pharmaceutical Company Ltd. (4016) Statistics
Valuation metrics
Market Cap -
Enterprise value 2.19B
Trailing P/E (ttm) 19.59
Forward P/E -
PEG ratio 1.15
Price/Sales (ttm) 4.15
Price/Book (mrq) 5.11
Enterprise Value/Revenue 4.44
Enterprise Value/EBITDA 16.77
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 61.38K
Average volume (90 days) 102.92K
Price summary
52-Week low 53.89
52-Week high 79.09
Beta -
50-Day moving average 60.27
200-Day moving average 84.03
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 1.38
Trailing annual dividend yield 0.0228%
5-Year annual dividend yield -
Payout ratio 0.68
Dividend Date 7 Apr 2026
Ex-Dividend Date 29 Mar 2026
Last split factor 7:4
Last split Date 12 May 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.21%
Operating margin 0.24%
Operational effectiveness
Return on assets 0.17%
Return on equity 0.26%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 14.58
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 3.09
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.54
Total debt (mrq) -
Total Debt/Equity (mrq) 0.2
Current ratio (mrq) 2.85%
Book value per share (mrq) 11.89
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
